| __timestamp | Bausch Health Companies Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 116287000 |
| Thursday, January 1, 2015 | 7853800000 | 136004000 |
| Friday, January 1, 2016 | 7063000000 | 203017000 |
| Sunday, January 1, 2017 | 6176000000 | 287023000 |
| Monday, January 1, 2018 | 6029000000 | 393541000 |
| Tuesday, January 1, 2019 | 6251000000 | 376095000 |
| Wednesday, January 1, 2020 | 5778000000 | 467938000 |
| Friday, January 1, 2021 | 6040000000 | 504714000 |
| Saturday, January 1, 2022 | 5760000000 | 580017000 |
| Sunday, January 1, 2023 | 6198000000 | 523742000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial for investors and stakeholders. This analysis highlights the gross profit trajectories of Bausch Health Companies Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Bausch Health, a major player, saw its gross profit peak in 2015, with a notable 30% increase from the previous year. However, it faced fluctuations, with a dip in 2020, before stabilizing around 6 billion USD in 2023. In contrast, Supernus Pharmaceuticals, a smaller entity, demonstrated consistent growth, with its gross profit increasing nearly fivefold over the decade. By 2023, Supernus achieved a gross profit of approximately 524 million USD, reflecting its strategic market positioning. This comparative analysis underscores the dynamic nature of the pharmaceutical sector, where both established giants and emerging companies navigate financial landscapes to sustain growth.
Key Insights on Gross Profit: Eli Lilly and Company vs Supernus Pharmaceuticals, Inc.
Key Insights on Gross Profit: AstraZeneca PLC vs Bausch Health Companies Inc.
Sanofi and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Bio-Techne Corporation and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Veracyte, Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Bausch Health Companies Inc. and Vericel Corporation
Bausch Health Companies Inc. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Bausch Health Companies Inc. vs Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Travere Therapeutics, Inc.
Gross Profit Comparison: Vericel Corporation and Supernus Pharmaceuticals, Inc. Trends